| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/10/2006 | US20060178297 Systems and methods for silencing expression of a gene in a cell and uses thereof |
| 08/10/2006 | US20060177934 Lentiviral LTR-deleted vector |
| 08/10/2006 | US20060177901 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| 08/10/2006 | US20060177866 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
| 08/10/2006 | US20060177861 Novel compositions and methods in cancer associated with altered expression of MCM3AP |
| 08/10/2006 | US20060177854 Hereditary hemochromatosis gene |
| 08/10/2006 | US20060177829 Contacting human beta-transducin repeat containing protein ( beta -TrCP) beta -TrCP1 or beta -TrCP2 with test compound and a phosphorylated cell division cycle 25A (Cdc25A) protein or a phosphorylated fragment thereof; detecting reduced binding compared to control; drug screening; anticarcinogenic agents |
| 08/10/2006 | US20060177819 genetic engineered polynucleotides comprising nucleotide sequences that code alphavirus replication recognition sequences, nonstructural proteins and heterologous polynucleotides; infectious, replication-defective alphavirus particles used for immunotherapy, treatment of cancer and gene delivery |
| 08/10/2006 | US20060177470 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 08/10/2006 | US20060177466 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/10/2006 | US20060177458 Compositions of CpG and saponin adjuvants and uses thereof |
| 08/10/2006 | US20060177457 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions |
| 08/10/2006 | US20060177428 Expression vector comprising nucleotide sequences coding endothelial growth factor for use in diagnosis, prevention and treatment of tumor disorders |
| 08/10/2006 | US20060177423 Composition and method for killing of tumours |
| 08/10/2006 | US20060177420 treatment of a tumor by administering to a patient an effective amount of active dendritic cells (DC) that are tumor-specific and secrete IL12 |
| 08/10/2006 | US20060177416 Based on biodegradable polymers containing polyester amide (PEA), polyester urethane (PEUR), and polyester urea (PEU) and immunostimulatory adjuvants; for delivery of compositions that bind to major histocompatibility complexes (MHC) alleles |
| 08/10/2006 | DE60024843T2 Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten Containing vaccines for oral use the liposome and a nucleic acid |
| 08/10/2006 | CA2598002A1 Compositions and methods for the therapeutic treatment of diabetes |
| 08/10/2006 | CA2597152A1 Use of myostatin (gdf-8) antagonists for treatment of sarcopenia (age-related muscle-wasting) |
| 08/10/2006 | CA2597146A1 Use of myostatin (gdf-8) antagonists for improving wound healing and preventif fibrotic disease |
| 08/10/2006 | CA2597040A1 Hiv tat-cd4 hybrid molecules and methods of use thereof |
| 08/10/2006 | CA2588183A1 Methods and compositions for modulating keratinocyte function |
| 08/09/2006 | EP1688496A2 Regulation of human P2Y1-like G protein-coupled receptor |
| 08/09/2006 | EP1688495A1 MU-1 member of the cytokine receptor family |
| 08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1687630A2 Diagnostics and therapeutics for diseases associated with aminopeptidase-like 1 (npepl1) |
| 08/09/2006 | EP1687449A2 Antisense modulation of kinesin-like 1 expression |
| 08/09/2006 | EP1687432A2 Compositions and methods for synergistic induction of antitumor immunity |
| 08/09/2006 | EP1687423A2 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases |
| 08/09/2006 | EP1687410A1 Antisense oligonucleotides optimized for kidney targeting |
| 08/09/2006 | EP1687333A2 Method for down-regulation of vegf |
| 08/09/2006 | EP1687329A2 Optimized expression of hpv 58 l1 in yeast |
| 08/09/2006 | EP1687323A2 Methods and compositions for seamless cloning of nucleic acid molecules |
| 08/09/2006 | EP1687322A2 Custom vectors for treating and preventing pancreatic cancer |
| 08/09/2006 | EP1687033A2 Enhancement of vaccine-induced immune responses and protection by heterologous boosting with alphavirus replicon vaccines |
| 08/09/2006 | EP1687032A1 Therapeutic regimen for treating cancer |
| 08/09/2006 | EP1687017A2 Methods and compositions for delivering polynucleotides |
| 08/09/2006 | EP1386973B1 Method of inferring diplotype configuration from the genotype of individual |
| 08/09/2006 | EP1354032B1 Gene regulation therapy involving ferritin |
| 08/09/2006 | EP1267954B1 Medical devices suitable for gene therapy regimens |
| 08/09/2006 | EP1146900B1 Dna vaccines against hantavirus infections |
| 08/09/2006 | EP1007098B1 Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides |
| 08/09/2006 | EP0935656B1 Hedgehog interacting proteins and uses related thereto |
| 08/09/2006 | EP0920305B1 Identification of genes altered in multiple myeloma |
| 08/09/2006 | EP0752004B1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
| 08/09/2006 | EP0724642B1 Nucleotide vector, composition containing such vector and vaccine for immunization against hepatitis |
| 08/09/2006 | CN1816745A Method for diagnosing and treating cancer |
| 08/09/2006 | CN1816626A Antisense oligonucleotide having anticancerous activity |
| 08/09/2006 | CN1816565A INF-like secretory protein |
| 08/09/2006 | CN1816281A Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 08/09/2006 | CN1816280A Dermal micro organs, methods and apparatuses for producing and using the same |
| 08/09/2006 | CN1814303A Microcapsule for promoting bone regeneration and its use |
| 08/09/2006 | CN1814302A Method for selectively increasing tumor cell sensitivity to ionic radiation |
| 08/09/2006 | CN1814295A Method for preparing gene therapeutic tissue engineering stent |
| 08/09/2006 | CN1814287A Prevention and treatment of amyloidogenic disease |
| 08/09/2006 | CN1268753C Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/09/2006 | CN1268748C Viral vaccine |
| 08/09/2006 | CN1268747C Recombinant newcastle disease virus RNA expression systems and vaccines |
| 08/09/2006 | CN1268744C Novel neurotrophic factors |
| 08/09/2006 | CN1268743C genetic construct for coding cell targeting part and heterologous precursor activating enzyme, and its application |
| 08/09/2006 | CN1268741C Therapy for 'alpha'-galactosidase deficiency |
| 08/09/2006 | CN1268641C 载脂蛋白类似物 Apolipoprotein analogues |
| 08/09/2006 | CN1268637C I (chlamydia) protein, gene sequence and uses thereof |
| 08/09/2006 | CN1268345C Method of treating hepatitis delta viral infection |
| 08/08/2006 | USRE39229 libraries of DNA sequences encoding zinc finger binding motifs for display on a particle; designing zinc finger binding polypeptides for binding to a target sequence |
| 08/08/2006 | US7087770 Compound containing a labile disulfide bond |
| 08/08/2006 | US7087743 Bleaching; skin disorders; genetic engineered nucleic acid; topical applying |
| 08/08/2006 | US7087741 Nucleic acids encoding novel proteins in enteroaggregative escherichia coli (EAEC) |
| 08/08/2006 | US7087725 Antibodies specifically reactive with a tumor necrosis factor related ligand |
| 08/08/2006 | US7087718 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 08/08/2006 | US7087715 Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses |
| 08/08/2006 | US7087713 Polypeptides that contain at least one immunogenic portion of one or more Mycobacterium proteins and DNA encoding said proteins |
| 08/08/2006 | US7087712 Peptide for triggering an immune reaction against tumor cells |
| 08/08/2006 | US7087585 Tripeptide of FcγRIIA |
| 08/08/2006 | US7087584 Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease |
| 08/08/2006 | US7087582 Cyclin-dependent kinase inhibitor; mixture with immunotherapy drug, cytokine and prodrug enzyme |
| 08/08/2006 | US7087581 Regeneration of sensitive cells with cell proliferative agents; cyclin-dependent kinase inhibitor; administering antibody |
| 08/08/2006 | US7087433 Altering lymphadenopthy associated cyclin dependent kinase viral gene expression in cells; viricides and rational drug design/screening |
| 08/08/2006 | US7087424 In animal or plants; administering an sugar acid such as galactonic acid, gluconic acid, galacturonic acid |
| 08/08/2006 | US7087394 Gene expression of polypeptides; induce glucose stimulation insulin production |
| 08/08/2006 | US7087390 CAIP-like gene family |
| 08/08/2006 | US7087230 Proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/03/2006 | WO2006081546A2 Inhibitor nucleic acids |
| 08/03/2006 | WO2006081192A2 Rnai modulation of the nogo-l or nogo-r gene and uses thereof |
| 08/03/2006 | WO2006080952A2 Improved modalities for the treatment of degenerative diseases of the retina |
| 08/03/2006 | WO2006080564A1 RNAi THERAPEUTIC AGENT HAVING NO ADVERSE SIDE EFFECT |
| 08/03/2006 | WO2006080508A1 Transdermal absorption preparation, sheet holding transdermal absorption preparation and transdermal absorption preparation holder |
| 08/03/2006 | WO2006080451A1 Process for producing coated fine particle |
| 08/03/2006 | WO2006080248A1 Linear mammalian artificial chromosome and method of constructing the same |
| 08/03/2006 | WO2006080118A1 Composition for inhibiting expression of target gene |
| 08/03/2006 | WO2006079508A1 Injectable agent for the targeted treatment of retinal ganglion cells |
| 08/03/2006 | WO2006079290A1 A recombinant sars-cov vaccine comprising attenuated vaccinia virus carriers |
| 08/03/2006 | WO2006079244A1 Recombined adenovirus p53 preparation for treating tumor |
| 08/03/2006 | WO2006079217A1 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 08/03/2006 | WO2006063247A3 Regulated expression of transgenes in the central nervous system of mammals |
| 08/03/2006 | WO2006061824A3 Chondrocyte-based implant for the delivery of therapeutic agents |
| 08/03/2006 | WO2006050274A3 Methods and compositions for cytokine expression and treatment of tumors |
| 08/03/2006 | WO2006048768A3 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 08/03/2006 | WO2006036445A3 Chimeric nk receptor and methods for treating cancer |
| 08/03/2006 | WO2005118789A3 Therapeutic delivery of adenosine into a tissue |